AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2025

Jul 30, 2025

34983_dirs_2025-07-30_12898a11-890b-47b5-8b72-afa6ade71435.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2025-07-29

Reporting Person: DOCHERTY JOHN MARTIN (Director, President & CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-29	common shares	P	5376	$0.928	Acquired	5376	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	54075	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$3	2026-04-26	Common Shares (18000)	18000	Direct
Stock Options	$3	2026-06-08	Common Shares (18334)	36334	Direct
Stock Options	$3	2026-09-01	Common Shares (15000)	51334	Direct
Stock Options	$2.91	2027-08-29	Common Shares (30000)	81334	Direct
Stock Options	$1.15	2028-10-26	Common Shares (30000)	111334	Direct
Stock Options	$2.36	2029-04-26	Common Shares (49500)	160834	Direct
Stock Options	$1.04	2030-05-15	Common Shares (150000)	310834	Direct